These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 39414396

  • 1. Involvement of pentraxin-3 in the development of hypertension but not left ventricular hypertrophy in male spontaneously hypertensive rats.
    Mkhize SA, Manilall A, Mokotedi L, Gunter S, Michel FS.
    Physiol Rep; 2024 Oct; 12(20):e70086. PubMed ID: 39414396
    [Abstract] [Full Text] [Related]

  • 2. Reduced periinfarction mortality as a result of long-term therapy with captopril but not hydralazine or propranolol in spontaneously hypertensive rats.
    Nguyen T, El Salibi E, Rouleau JL.
    J Cardiovasc Pharmacol; 1998 Dec; 32(6):884-95. PubMed ID: 9869493
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
    Ikeda Y, Nakamura T, Takano H, Kimura H, Obata JE, Takeda S, Hata A, Shido K, Mochizuki S, Yoshida Y.
    J Lab Clin Med; 2000 Apr; 135(4):353-9. PubMed ID: 10779052
    [Abstract] [Full Text] [Related]

  • 4. [Effect of chronic antihypertensive treatment on ischemia-induced lethal ventricular tachyarrhythmias and electrophysiological property in hypertrophied rat hearts].
    Yokoshiki H.
    Hokkaido Igaku Zasshi; 1993 Nov; 68(6):862-72. PubMed ID: 8112711
    [Abstract] [Full Text] [Related]

  • 5. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK, Dubinion JH, Mi Z.
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [Abstract] [Full Text] [Related]

  • 6. Role of lowering arterial pressure on maximal coronary flow with and without regression of cardiac hypertrophy.
    Canby CA, Tomanek RJ.
    Am J Physiol; 1989 Oct; 257(4 Pt 2):H1110-8. PubMed ID: 2529781
    [Abstract] [Full Text] [Related]

  • 7. Upregulation of ligand, receptor system, and amidating activity of adrenomedullin in left ventricular hypertrophy of severely hypertensive rats: effects of angiotensin-converting enzyme inhibitors and diuretic.
    Wang X, Nishikimi T, Akimoto K, Tadokoro K, Mori Y, Minamino N.
    J Hypertens; 2003 Jun; 21(6):1171-81. PubMed ID: 12777955
    [Abstract] [Full Text] [Related]

  • 8. Alteration of cardiac collagen phenotypes in hypertensive hypertrophy: role of blood pressure.
    Mukherjee D, Sen S.
    J Mol Cell Cardiol; 1993 Feb; 25(2):185-96. PubMed ID: 8474126
    [Abstract] [Full Text] [Related]

  • 9. Left ventricular hypertrophy does not prevent heart failure in experimental hypertension.
    Hernán Gómez Llambí H, Cao G, Donato M, Suárez D, Ottaviano G, Müller A, Buchholz B, Gelpi R, Otero-Losada M, Milei J.
    Int J Cardiol; 2017 Jul 01; 238():57-65. PubMed ID: 28410843
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
    Kojima M, Shiojima I, Yamazaki T, Komuro I, Zou Z, Wang Y, Mizuno T, Ueki K, Tobe K, Kadowaki T.
    Circulation; 1994 May 01; 89(5):2204-11. PubMed ID: 8181146
    [Abstract] [Full Text] [Related]

  • 11. Improvement in fatty acid utilization in relation to a change in left ventricular hypertrophy in spontaneously hypertensive rats.
    Ono T, Kohya T, Tsukamoto E, Mochizuki T, Itoh K, Itoh Y, Tomita F, Tamaki N, Kitabatake A.
    Jpn Circ J; 2000 Feb 01; 64(2):117-20. PubMed ID: 10716525
    [Abstract] [Full Text] [Related]

  • 12. Attenuation of cardiac failure, dilatation, damage, and detrimental interstitial remodeling without regression of hypertrophy in hypertensive rats.
    Tsotetsi OJ, Woodiwiss AJ, Netjhardt M, Qubu D, Brooksbank R, Norton GR.
    Hypertension; 2001 Oct 01; 38(4):846-51. PubMed ID: 11641297
    [Abstract] [Full Text] [Related]

  • 13. Role of cardiac hypertrophy in reducing the sensitivity of cardiopulmonary reflex control of renal sympathetic nerve activity in spontaneously hypertensive rats.
    de Andrade TU, Abreu GR, Moysés MR, de Melo Cabral A, Bissoli NS.
    Clin Exp Pharmacol Physiol; 2008 Sep 01; 35(9):1104-8. PubMed ID: 18788121
    [Abstract] [Full Text] [Related]

  • 14. Changes in aortic levels of tropoelastin mRNA following treatment of rats with the antihypertensive drugs captopril and hydralazine.
    Alden SM, Pierce RA, Tozzi CA, Mackenzie JW, Deak SB, Boyd CD.
    J Surg Res; 1991 Dec 01; 51(6):491-4. PubMed ID: 1943085
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin-(1-7) blockade attenuates captopril- or hydralazine-induced cardiovascular protection in spontaneously hypertensive rats treated with NG-nitro-L-arginine methyl ester.
    Benter IF, Yousif MH, Al-Saleh FM, Raghupathy R, Chappell MC, Diz DI.
    J Cardiovasc Pharmacol; 2011 May 01; 57(5):559-67. PubMed ID: 21326110
    [Abstract] [Full Text] [Related]

  • 16. Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats.
    Owens GK.
    Hypertension; 1987 Feb 01; 9(2):178-87. PubMed ID: 3546119
    [Abstract] [Full Text] [Related]

  • 17. Changes in contractile protein gene expression with ageing and with captopril-induced regression of hypertrophy in the spontaneously hypertensive rats.
    Dalton GR, Jones JV, Levi AJ, Levy A.
    J Hypertens; 2000 Sep 01; 18(9):1297-306. PubMed ID: 10994761
    [Abstract] [Full Text] [Related]

  • 18. Vascular remodeling and improvement of coronary reserve after hydralazine treatment in spontaneously hypertensive rats.
    Anderson PG, Bishop SP, Digerness SB.
    Circ Res; 1989 Jun 01; 64(6):1127-36. PubMed ID: 2524290
    [Abstract] [Full Text] [Related]

  • 19. Regression of hypertrophy in small resistance vessels.
    Sano T, Tarazi RC.
    J Hypertens Suppl; 1985 Dec 01; 3(3):S489-91. PubMed ID: 2856775
    [Abstract] [Full Text] [Related]

  • 20. Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats.
    Simko F, Pechanova O, Pelouch V, Krajcirovicova K, Mullerova M, Bednarova K, Adamcova M, Paulis L.
    J Hypertens Suppl; 2009 Aug 01; 27(6):S5-10. PubMed ID: 19633453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.